ALZHEIMER DISEASE, EARLY ONSET
Clinical trials for ALZHEIMER DISEASE, EARLY ONSET explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE, EARLY ONSET trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, EARLY ONSET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could flickering lights and tones slow Alzheimer's? major trial underway
Disease control OngoingThis study tests a device that delivers light and sound stimulation to people with mild to moderate Alzheimer's disease. About 670 participants will use either the active device or a sham (inactive) device for one hour daily over 12 months. The goal is to see if the stimulation c…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:20 UTC
-
Could 'Zombie Cell' cleaners slow Alzheimer's? new trial tests safety
Disease control OngoingThis study tests whether senolytic drugs—which clear out aged, damaged cells—are safe and feasible for people with early Alzheimer's or mild cognitive impairment. About 48 adults aged 60 and older with elevated tau protein will receive either the drug or a placebo. The main goal …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 05:20 UTC
-
Brain pacemaker aims to fight Alzheimer's memory decline
Disease control ENROLLING_BY_INVITATIONThis study tests whether deep brain stimulation (DBS) can improve thinking and memory in people recently diagnosed with early Alzheimer's disease. Two participants will have electrodes implanted in a brain area that produces a key memory chemical. The goal is to see if daily one-…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New Alzheimer's drug shows promise in Early-Stage trial
Disease control OngoingThis study tests a new medicine called PMN310 in people with early Alzheimer's disease. The goal is to see if it is safe and how it affects Alzheimer's-related changes in the body. About 144 volunteers will receive multiple doses of the drug or a placebo. This is an early-phase t…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: ProMis Neurosciences, Inc • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Mild brain zaps may help Alzheimer's patients remember words
Symptom relief OngoingThis study tests whether a safe, painless brain stimulation technique called tDCS can improve verbal learning in people with Alzheimer's disease. About 94 participants with either typical memory-loss Alzheimer's or a language-focused form will receive active or sham stimulation w…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 17, 2026 05:09 UTC
-
Could a High-Fat diet help early Alzheimer's? new study investigates
Symptom relief OngoingThis study looks at whether people with early-stage Alzheimer's can safely follow a ketogenic diet for a full year. The diet shifts the body to burn fat for energy, producing ketones that may fuel the brain when glucose use declines. Researchers will measure brain metabolism, thi…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Could magnetic pulses boost memory in early Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a type of non-invasive brain stimulation called theta-burst stimulation (TBS) can help improve cognitive function in people diagnosed with young-onset Alzheimer's disease (before age 65). Researchers will measure changes in memory and thinking tests, a…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Scientists scan brains to uncover Alzheimer's protein buildup
Knowledge-focused OngoingThis study uses special brain scans to measure two proteins, amyloid and tau, in people with different forms of Alzheimer's disease. Researchers want to see how these protein levels change over one year. The study involves 60 adults with typical or atypical Alzheimer's, including…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC